Join NATF in the fight against blood clots. Donate today. Make a donation

Event Description

Join us for the 2018 NATF Summit: Strategic Interventions to Conquer the Cardiometabolic Syndrome and Cardiovascular Risk in Diabetes!

This special dinner program will provide a comprehensive review of the most important changes and advances impacting the care of patients who have, or are at risk for, diabetes and cardiovascular disease. Updates in treatment, diagnosis, and prevention will be given by leading experts in the fields of endocrinology, cardiology, and nephrology. This CME accredited program is for any healthcare provider involved in the care of patients with, or at risk for developing, diabetes and cardiovascular disease, and chronic kidney disease.

Accreditation

PHYSICIANS: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

ScientiaCME designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSE PRACTITIONERS (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s) TM from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)TM.

PHYSICIAN ASSISTANTS: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

NURSES: Nurses may claim credit for activities approved for AMA PRA Category 1 Credit(s)™ in most states for up to 50% of the nursing requirement for recertification.

MEDICAL PRACTICE EXECUTIVES: The American College of Medical Practice Executives accepts AMA PRA Category 1 Credit(s) TM from organizations accredited by ACCME.

PHARMACISTS: ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 2.5 hours (0.25 CEUs) of continuing education. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE # – 0574-9999-18-016-L01-P

This course is not valid for CE credit after 10/26/2018. Successful completion of the post-test and completion of the program evaluation is required to obtain a CME certificate.

Event Location

Fairmont Copley Plaza

This luxury downtown Boston landmark hotel has been a symbol of the city’s rich history and elegance since its gala opening in 1912. Centrally located in Boston’s historic Back Bay, Fairmont Copley Plaza sits steps away from the Boston Public Library, historic Beacon Hill, and the Freedom Trail. This historic landmark Back Bay hotel is a luxury four diamond property located only a few blocks from the Hynes Convention Center, Copley Place Mall and the boutiques of Newbury Street.

Agenda

5:30 p.m. – 6:20 p.m. 

Registration and Cocktails in the Venetian Room

6:20 p.m. – 6:30 p.m. 

Seating in Oval Room

6:30 p.m. – 6:35 p.m. 

Welcome and Introductions
Samuel Z. Goldhaber, MD

6:35 p.m. – 6:40 p.m. 
Case Study
Aaron Kithcart, MD, PhD
6:40 p.m. – 6:50 p.m. 

Reducing Cardiovascular Risk in Diabetes: Attacking from All the Angles
Benjamin Scirica, MD

6:50 p.m. – 7:00 p.m. 
Putting the Patient First: Educational Interventions for Diabetes Control and Cardiovascular Risk Reduction
Greeshma Shetty, MD
7:00 p.m. – 7:10 p.m. 
Panel Discussion and Audience Q&A
Umberto Campia, MD, MS
7:10 p.m. – 7:15 p.m. 

Case Study
Karola Jering, MD

7:15 p.m. – 7:25 p.m. 

Fall Brawl Debate: Why Delay the Inevitable? This Patient Should Start a PCSK9 Inhibitor
Deepak Bhatt, MD, MPH

7:25 p.m. – 7:35 p.m. 
Fall Brawl Debate: Not So Fast! Don’t Give Up on Statins Just Yet
 Jorge Plutzky, MD
7:35 p.m. – 7:45 p.m. 
Panel Discussion and Audience Q&A
Christian Ruff, MD, MPH
7:45 p.m. – 7:50 p.m. 
Case Study
Brian Bergmark, MD
7:50 p.m. – 8:00 p.m. 

Playing Against a Stacked Deck: Managing Cardiovascular Risk in Chronic Kidney Disease
David Charytan, MD

8:00 p.m. – 8:10 p.m. 

Crossing the Chasm of Socioeconomic Disparities in Cardiovascular Risk Reduction
Eldrin Lewis, MD, MPH

8:10 p.m. – 8:20 p.m. 
Panel Discussion and Audience Q&A
Gregory Piazza, MD, MS
8:20 p.m. – 8:25 p.m. 
Introduction to Keynote Speaker: Margo Minissian, PhD, ACNP
Gregory Piazza, MD, MS
8:25 p.m. – 8:55 p.m. 
Keynote Presentation: Tearing Down Walls and Building Bridges – How We Can Succeed at Cardiovascular Prevention in an Era of Racial and Ethnic Disparities
Margo Minissian, PhD, ACNP, FAHA
8:55 p.m. – 9:00 p.m. 
Closing Remarks/Adjourn
Gregory Piazza, MD, MS

Speakers

Brian Bergmark, MD
Instructor of Medicine, Harvard Medical School, Interventional Cardiologist, Brigham and Woman's Hospital

Brian Bergmark, MD is an Interventional Cardiologist at the Brigham and Women’s Hospital and Instructor in Medicine at Harvard Medical School. He is a member of the Brigham’s Chronic Total Occlusion program and his academic work in the Cardiovascular Innovation group focuses on clinical trials in cardiometabolic disease. He earned his undergraduate degree from Stanford University and medical degree from Harvard Medical School with subsequent residency training, Cardiovascular Medicine fellowship, and Interventional Cardiology fellowship at the Brigham and Women’s Hospital.

Deepak Bhatt, MD, MPH
Professor of Medicine, Harvard Medical School; Executive Director: Interventional Cardiovascular Programs, Brigham and Women's Hospital

Dr. Deepak L. Bhatt is the executive director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital (BWH). He is also a professor of medicine at Harvard Medical School (HMS) and editor-in-chief of the Harvard Heart Letter. Dr. Bhatt specializes in cardiovascular medicine and interventional cardiology.

Dr. Bhatt received his medical degree from Cornell University and his Master in Public Health degree from Harvard University. He completed an internal medicine residency at the Hospital of the University of Pennsylvania. Dr. Bhatt completed fellowships in cardiology, interventional cardiology, and cerebral and peripheral vascular intervention, as well as serving as Chief Interventional Fellow at Cleveland Clinic. He also served as Associate Director of the Cleveland Clinic Cardiovascular Coordinating Center. Dr. Bhatt was then recruited to be the Chief of Cardiology at VA Boston Healthcare System and served in that role for several years.

Umberto Campia, MD, MS
Assistant Professor of Medicine, Harvard Medical School; Vascular Medicine Specialist, Brigham and Women's Hospital

Dr. Campia is a cardiologist and vascular medicine specialist at Brigham and Women’s Hospitaland member of the faculty at Harvard Medical School in Boston, MA. Previously, he was sectiondirector of vascular medicine at the MedStar Heart and Vascular Institute and Asst. Prof. of medicine at Georgetown University Medical School, both in Washington DC. Dr. Campia completed his training in cardiology and vascular medicine at Northwestern University Feinberg School of Medicinein Chicago, IL. He is board certified in internal medicine, cardiology, vascular medicine, adult echocardiography, and vascular ultrasound interpretation. His clinical activities include inpatient cardiology and vascular medicine ward, outpatient general cardiology and vascular medicine clinic, as well as reading in the vascular lab. His main research interest is the study of the mechanisms of vascular damage in patients with obesity, high blood pressure, and diabetes.

David Charytan, MD
Assistant Professor of Medicine, Harvard Medical School; Director, ICU Nephrology, Brigham and Women's Hospital

David Charytan, MD MSc is an Associate Professor of Medicine at Harvard Medical School and Associate Staff Physician in the Renal Division at Brigham & Women’s Hospital in Boston where he is the Director of ICU Nephrology. He serves as the principal investigator of several NIH-funded grants, is a founding member of the Hemodialysis Novel Therapies Network and is an experienced clinical trialist. His research focuses on cardiovascular disease in the setting of chronic kidney disease.

Samuel Z. Goldhaber, MD
Professor of Medicine, Harvard Medical School; Interim Chief of the Division of Cardiovascular Medicine, Section Head of Vascular Medicine, Brigham and Women’s Hospital

Samuel Z. Goldhaber, MD, Professor of Medicine at Harvard Medical School, is the Interim Chief of  the division of Cardiovascular Medicine and Section Head of the Vascular Medicine Division at Brigham and Women’s Hospital (BWH). He is Director of the BWH Thrombosis Research Group, medical co-director of the BWH Anticoagulation Management Service, and serves as Principal Investigator of a broad range of randomized clinical trials and observational studies related to the prevention, treatment, and epidemiology of pulmonary embolism, deep vein thrombosis, stroke prevention in atrial fibrillation, and prevention of recurrent myocardial infarction.

Dr. Goldhaber is President and a Founding Director of the North American Thrombosis Forum. For his work on prevention of venous thromboembolism, Dr. Goldhaber has received the Certificate of Appreciation from the Surgeon General of the United States.

He chairs the Steering Committee of the National Heart, Lung, and Blood Institute (NHLBI)-sponsored ATTRACT Trial of DVT treatment. Dr. Goldhaber is a member of the Steering Committee and is the U.S. National Coordinator of the GARFIELD Atrial Fibrillation cohort study and the GARFIELD Venous Thromboembolism cohort study. He is a Section Editor for Circulation and for Thrombosis and Haemostasis. He also has a busy practice of general cardiology, venous thromboembolism, and atrial fibrillation patients.

Karola Jering, MD
Fellow, Brigham and Women's Hospital

Dr. Jering received her medical degree from Vanderbilt University School of Medicine. She completed her internal medicine residency at Johns Hopkins Hospital and is currently a fellow in cardiovascular medicine at the Brigham and Women’s Hospital. Throughout residency and fellowship she has received multiple awards in clinical care and teaching. Her clinical and research interests center around advanced heart failure in a critical care setting.

Aaron Kithcart, MD, PhD
Vascular Medicine Fellow, Brigham and Women's Hospital

Dr. Kithcart is a research fellow at Brigham and Women’s Hospital in Boston, Massachusetts. He is interested in the mechanisms by which the immune system plays a role in the progression of atherosclerosis, including the development of superficial erosion plaques. He developed a novel approach using zebrafish to study ways in which the innate immune system facilitates lipid depositionand vascular injury. Dr. Kithcart is the recipient of the LaDue Fellowship from Harvard Medical School, which supports cardiologists pursuing careers in biomedical research. He also sees patients one day a week in clinic. Dr. Kithcart completed his internal medicine residency at the University of Washington, and fellowships in cardiology and vascular medicine at Brigham and Women’s Hospital.

Eldrin Lewis, MD, MPH
Associate Professor, Harvard Medical School; Staff Physician, Cardiovascular Division, Brigham and Women's Hospital

Dr. Lewis is in his 15th year as a faculty member in the cardiovascular division at Brigham and Women’s Hospital and is an Associate Professor of Medicine at Harvard Medical School. He received his B.S. Degree in Pre-medicine at Pennsylvania State University, his M.D. at University of Pennsylvania School of Medicine where he won the Joel Gordon Miller Award for community service and leadership, and Master’s in Public Health degree from Harvard School of Public Health. He completed training in internal medicine and cardiology at Brigham and Women’s Hospital in Boston followed by an additional year of subspecialty training in heart failure and transplantation. Dr. Lewis was one of the first recipients of the Minority Faculty Development Award, which is a 7 year award given to promising young physicians with research potential. He is involved with several large, international clinical trials and has approximately 130 publications during his career. He also received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure and several grants from the National Institutes of Health. Dr. Lewis is Vice Chair of the Clinical Cardiology Council of American Heart Association Heart Failure and Director of the Cardiology clerkship for Harvard Medical School students who rotate at Brigham and Women’s Hospital. He is also on the National AHA Research Committee, Chair of Association of Black Cardiologist Research Committee, and a member of the AHA Founders Affiliate Board of Directors. Dr. Lewis is an international expert in the area of quality of life and heart failure and serves on scientific committees to review grants for the American Heart Association and the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials. He is also on several editorial boards for cardiovascular journals and just completed his role as an Associate Editor for Circulation-Heart Failure.

Margo Minissian, PhD, ACNP, FAHA
Nurse Scientist, Clinical Lipid Specialist, Cardiology Nurse Practitioner, Cedars-Sinai Heart Institute

Margo B. Minissian, PhD, ACNP is a Nurse Scientist, Cardiology Nurse Practitioner and Clinical Lipid Specialist at the Barbra Streisand Women’s Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center. The center is designed to help women reduce their chances of heart disease through a preventive approach, including state-of-the-art screening and diagnostic testing. Her primary research interests focus on cardiovascular prevention. Dr. Minissian is funded by the National Institutes of Health, National Heart, Lung, and Blood Institute to complete heart health screenings in ethnic minority women. She has partnered with local nursing organizations to complete this study which takes place in minority communities in Los Angeles. Her second NIH funded study washer doctoral project, “Is Spontaneous Preterm Delivery Associated with Clustering of Maternal Cardiovascular Risk Markers and Impaired Vascular Function? The SPACE Study”. Dr. Minissianwas also awarded the American Heart Association Western States Affiliate Summer 2014 Pre-doctoral Fellowship, the American Nurses Foundation Nurse Scholar Fellowship and was the UCLA Dean’s Scholar Fellow and a UCLA Regents Scholar. She recently published in the journal Circulation, the State of the Art manuscript which highlighted a 2-fold increased risk for future heart disease in women with spontaneous preterm delivery. Dr. Minissian also competed in the American College of Cardiology Young Investigator Award as the first PhD nurse and was 1st runner up with her Preterm Delivery work in the Clinical Cardiology Competition. Dr. Minissian has spoken at many professional organizations nation-wide discussing the epidemic of women and heart disease, Adverse Pregnancy Outcomes and dyslipidemia complicated by statin myalgias. In addition, Dr. Minissian was co-author of the 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Riskand the ACC/ AHA Secondary Prevention Guidelines in which she chaired the smoking cessation section. She has presented at the Puerto Rico, Minnesota, Montana, Kentucky, New York, Washington and California Chapters of the American College of Cardiology to name a few.

Gregory Piazza, MD, MS
Assistant Professor of Medicine, Harvard University; Staff Physician, Cardiovascular Medicine Division, Brigham and Women's Hospital

Dr. Piazza is an Assistant Professor of Medicine, Harvard Medical School and staff physician in the Cardiovascular Medicine Division at the Brigham and Women’s Hospital (BWH). Dr. Piazza received his medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts and completed his medicine residency and Fellowship in Cardiovascular Disease at the Beth Israel Deaconess Medical Center in Boston. He served as Chief Medical Resident for the Department of Medicine at Beth Israel Deaconess Medical Center. Dr. Piazza completed an additional fellowship in Vascular Medicine through a National Heart, Lung and Blood Institute (NHLBI) sponsored training program at BWH. During his Vascular Medicine fellowship, he also completed a Masters Degree in Epidemiology at the Harvard School of Public Health. Dr. Piazza’s research interests include the epidemiology, pathophysiology, diagnosis, treatment, and prevention of venous thromboembolism; improving stroke prevention in patients with atrial fibrillation; and prevention of acute coronary syndromes.

Jorge Plutzky, MD
Associate Professor of Medicine, Harvard Medical School; Director, The Vascular Disease Prevention Program, Brigham and Women's Hospital

Dr. Jorge Plutzky is director of the Vascular Disease Prevention Program and director of Preventive Cardiology at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School.

Dr. Plutzky received his medical degree from University of North Carolina at Chapel Hill School of Medicine. He completed a residency in internal medicine at BWH and West Roxbury Veterans Administration Medical Center (now VA Boston Healthcare Systems), as well as a fellowship in cardiology at BWH. Dr. Plutzky is board certified in internal medicine and cardiovascular disease.

Christian Ruff, MD, MPH
Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Cardiovascular Division, Brigham and Women's Hospital

Dr. Ruff is currently an Associate Physician in the Cardiovascular Division at Brigham and Women’s Hospital in Boston, MA and an Assistant Professor of Medicine at Harvard Medical School. He was a lead co-investigator for the ENGAGE AF-TIMI 48 study evaluating the investigational, oral, once-daily, factor Xa inhibitor edoxaban for the prevention of stroke or systemic embolic events in patients with non-valvular atrial fibrillation.

Dr. Ruff graduated from Harvard University with a degree in Neurobiology and earned his medical degree at the Johns Hopkins University School of Medicine and his Masters of Public Health at the Harvard School of Public Health. Dr. Ruff completed his internal medicine residency and cardiovascular medicine fellowship at the Brigham and Women’s Hospital.

Benjamin Scirica, MD
Associate Professor, Harvard Medical School; Cardiovascular Medicine Specialist, Brigham and Women's Hospital

Dr. Scirica graduated from Harvard Medical School and trained in internal medicine and cardiovascular medicine at Brigham and Women’s Hospital in Boston, Massachusetts. He has a Master of Public Health degree from Harvard School of Public Health. He is currently Associate Professor of Medicine at Harvard Medical School and Senior Investigator at the TIMI Study Group (an academic research organization based at Brigham and Women’s Hospital that has performed over 70 clinical trials in atherosclerotic heart disease). He is Director of Innovation in the cardiovascular division at Brigham and Women’s Hospital. His research interests center on the identification and application of novel cardiac biomarkers and therapeutic strategies across the spectrum of cardiometabolic disease. He was principal investigator of the AVANT GARDE-TIMI 43 trial and CAMELLIA-TIMI 61 and co-investigator of the MERLIN-TIMI 36, TRA 2Pº-TIMI 50, and SAVOR-TIMI 53 trials. He is the Director of the TIMI ECG Core Laboratory, which has analyzed over 20,000 continuous and static ECGs from multiple trials in acute coronary syndromes. Dr. Scirica has authored or co-authored over 100 peer-reviewed articles, serves on the editorial board of ACCEL, and is a reviewer for multiple journals, including The Lancet, Circulation and Journal of the American College of Cardiology (JACC). He practices in the Levine Cardiac Intensive Care Unit, cardiology in-patient service, and the Watkins Cardiovascular Clinic at Brigham and Women’s Hospital.

Greeshma Shetty, MD
Instructor of Medicine, Harvard Medical School; Clinical Faculty, Joslin Diabetes Center

Greeshma K Shetty, M.D., is a board certified endocrinologist at Joslin Diabetes Center and Beth Israel Deaconess Medical Center. She is the co-director of the Asian American Diabetes Initiative at the Joslin clinic. She is the Associate Endocrine Fellowshi p Program Director for the combined Beth Israel Deaconess Medical Center and Joslin Clinic Endocrinology and Diabetes fellowship.

She attended medical school at Albany Medical College and completed her residency in Internal Medicine and Endocrine fellowship at the Beth Israel Deaconess Medical Center, Harvard Medical School.  Her interests include Diabetes Technology, Insulin Pump Therapy, and culturally competent diabetes prevention and treatment in minority patient populations.

Join NATF in the fight against blood clots. Donate today.

Make a donation

Twitter Facebook YouTube